Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cerebrospinal Fluid Biomarkers for Diagnosis and the Prognostication of Acute Ischemic Stroke: A Systematic Review. | Int J Mol Sci | 2023 | 37446092 | PubTator, text mining | PubMed |
| Use of a transparent cap with a slit facilitates endoscopic injection sclerotherapy of esophageal varices. | Endoscopy | 2023 | 37442177 | PubTator, text mining | PubMed |
Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients. | Eur J Neurol | 2023 | 37431060 | PubTator, text mining | PubMed |
| Anxiety adds the risk of cognitive progression and is associated with axon/synapse degeneration among cognitively unimpaired older adults. | EBioMedicine | 2023 | 37429081 | PubTator, text mining | PubMed |
| A beginner's guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration. | Sci Data | 2023 | 37414779 | PubTator, text mining | PubMed |
| Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease. | Sci Transl Med | 2023 | 37406134 | PubTator, text mining | PubMed |
| Genetic mechanisms for impaired synaptic plasticity in schizophrenia revealed by computational modelling. | bioRxiv | 2023 | 37398070 | PubTator, text mining | PubMed |
| Developments in understanding early onset Alzheimer's disease. | Alzheimers Dement | 2023 | 37390354 | PubTator, text mining | PubMed |
| Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers. | Curr Opin Neurol | 2023 | 37387459 | PubTator, text mining | PubMed |
| Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future. | Signal Transduct Target Ther | 2023 | 37386015 | PubTator, text mining | PubMed |
| CaMKK2 is not involved in contraction-stimulated AMPK activation and glucose uptake in skeletal muscle. | Mol Metab | 2023 | 37380024 | PubTator, text mining | PubMed |
| Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline. | Brain Commun | 2023 | 37377978 | PubTator, text mining | PubMed |
| CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease. | Brain | 2023 | 37348871 | PubTator, text mining | PubMed |
| Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? | Front Pharmacol | 2023 | 37332353 | PubTator, text mining | PubMed |
| Compensatory Mechanisms in Early Alzheimer's Disease and Clinical Setting: The Need for Novel Neuropsychological Strategies. | J Alzheimers Dis Rep | 2023 | 37313485 | PubTator, text mining | PubMed |
| Exosomes in brain diseases: Pathogenesis and therapeutic targets. | MedComm (2020) | 2023 | 37313330 | PubTator, text mining | PubMed |
| Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37298224 | PubTator, text mining | PubMed |
| Synaptic memory and CaMKII. | Physiol Rev | 2023 | 37290118 | PubTator, text mining | PubMed |
| Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis. | JCI Insight | 2023 | 37279077 | PubTator, text mining | PubMed |
| Gamma neuromodulation improves episodic memory and its associated network in amnestic mild cognitive impairment: a pilot study. | Neurobiol Aging | 2023 | 37276822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers?page=15